SG Americas Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.7M Buy
66,985
+48,027
+253% +$13.8M 0.02% 567
2025
Q4
$5.74M Buy
18,958
+12,544
+196% +$3.91M 0.01% 1033
2025
Q3
$1.8M Buy
6,414
+5,600
+688% +$1.52M 0.01% 1006
2025
Q2
$196K Sell
814
-1,736
-68% -$410K ﹤0.01% 2268
2025
Q1
$621K Sell
2,550
-671
-21% -$202K ﹤0.01% 1598
2024
Q4
$1.06M Buy
3,221
+1,966
+157% +$667K ﹤0.01% 845
2024
Q3
$420K Sell
1,255
-607
-33% -$193K ﹤0.01% 1842
2024
Q2
$509K Sell
1,862
-4,930
-73% -$1.43M ﹤0.01% 1674
2024
Q1
$2.35M Buy
6,792
+5,049
+290% +$1.66M 0.01% 814
2023
Q4
$563K Buy
+1,743
New +$546K 0.01% 1402
2023
Q3
Sell
-1,155
Closed -$438K 3107
2023
Q2
$438K Sell
1,155
-603
-34% -$245K ﹤0.01% 1454
2023
Q1
$842K Buy
1,758
+152
+9% +$71.2K 0.01% 1269
2022
Q4
$675K Sell
1,606
-2,158
-57% -$871K 0.01% 1278
2022
Q3
$1.57M Buy
3,764
+3,188
+553% +$1.59M 0.02% 721
2022
Q2
$285K Sell
576
-1,072
-65% -$558K ﹤0.01% 2407
2022
Q1
$928K Sell
1,648
-16,767
-91% -$10.1M 0.01% 1479
2021
Q4
$13.9M Buy
18,415
+15,146
+463% +$11.3M 0.09% 197
2021
Q3
$2.44M Sell
3,269
-6,420
-66% -$4.81M 0.01% 1091
2021
Q2
$6.24M Buy
9,689
+6,394
+194% +$3.89M 0.03% 499
2021
Q1
$1.88M Buy
3,295
+721
+28% +$427K 0.01% 1083
2020
Q4
$1.5M Buy
2,574
+1,825
+244% +$1.04M 0.01% 1277
2020
Q3
$386K Sell
749
-1,152
-61% -$583K ﹤0.01% 1796
2020
Q2
$858K Sell
1,901
-145
-7% -$64K 0.01% 1563
2020
Q1
$717K Buy
2,046
+289
+16% +$106K 0.01% 1537
2019
Q4
$650K Buy
1,757
+256
+17% +$90.3K 0.01% 1568
2019
Q3
$499K Sell
1,501
-414
-22% -$135K ﹤0.01% 1888
2019
Q2
$599K Sell
1,915
-202
-10% -$60.5K ﹤0.01% 1772
2019
Q1
$647K Buy
2,117
+1,334
+170% +$360K 0.01% 1615
2018
Q4
$182K Sell
783
-1,501
-66% -$403K ﹤0.01% 2432
2018
Q3
$715K Sell
2,284
-479
-17% -$149K 0.01% 1926
2018
Q2
$797K Sell
2,763
-420
-13% -$116K 0.01% 1652
2018
Q1
$796K Sell
3,183
-6,700
-68% -$1.71M 0.01% 1534
2017
Q4
$2.36M Buy
9,883
+9,138
+1,227% +$2.21M 0.03% 768
2017
Q3
$166K Sell
745
-8,041
-92% -$1.81M ﹤0.01% 2746
2017
Q2
$1.99M Buy
8,786
+2,538
+41% +$553K 0.02% 896
2017
Q1
$1.25M Buy
6,248
+3,451
+123% +$665K 0.01% 1221
2016
Q4
$510K Buy
2,797
+1,606
+135% +$274K ﹤0.01% 1686
2016
Q3
$195K Sell
1,191
-6,126
-84% -$930K ﹤0.01% 2518
2016
Q2
$1.05M Buy
7,317
+1,270
+21% +$181K 0.01% 1264
2016
Q1
$827K Sell
6,047
-2,755
-31% -$362K 0.01% 1439
2015
Q4
$1.22M Buy
+8,802
New +$1.22M 0.01% 1009
2015
Q3
Sell
-1,951
Closed -$294K 2119
2015
Q2
$294K Buy
+1,951
New +$279K ﹤0.01% 1786
2015
Q1
Sell
-2,148
Closed -$259K 2546
2014
Q4
$259K Sell
2,148
-834
-28% -$96K ﹤0.01% 2198
2014
Q3
$338K Sell
2,982
-8,472
-74% -$1M ﹤0.01% 1682
2014
Q2
$1.37M Buy
11,454
+8,732
+321% +$1.07M 0.01% 1179
2014
Q1
$349K Sell
2,722
-10
-0.4% -$1.28K ﹤0.01% 1664
2013
Q4
$338K Sell
2,732
-4,825
-64% -$588K ﹤0.01% 1767
2013
Q3
$888K Buy
7,557
+4,979
+193% +$587K ﹤0.01% 1343
2013
Q2
$289K Buy
+2,578
New +$302K ﹤0.01% 1538

Other funds holding BIO